0
0.5
1
1.5
2+
Mortality
97%
Improvement
Relative Risk
Case
-30%
Fluvoxamine for COVID-19 Nemani et al. Prophylaxis
Is prophylaxis with fluvoxamine beneficial for COVID-19?
Retrospective 1,958 patients in the USA (March - July 2020)
More cases with fluvoxamine (not stat. sig., p=0.16)
c19early.org
Nemani et al., JAMA Network Open, May 2022
Favors fluvoxamine
Favors control